InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
前日終値
$0.521
+$0.041 · +8.54%
日中の時刻はETです。市場データは遅延する場合があります。
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
日中レンジ
現在 $0.521
52週レンジ
現在 $0.521
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
67
割安
センチメント
68
強気
リスク
69
高リスク
モメンタム
17
強い下落
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
日中レンジ
現在 $0.521
52週レンジ
現在 $0.521
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 897.9万 USD | 700.9万 USD | 620.5万 USD | 517.1万 USD | 449.5万 USD |
| 売上原価 | 633万 USD | 550.3万 USD | 439.8万 USD | 405.4万 USD | 374.1万 USD |
| 粗利益 | 264.9万 USD | 150.6万 USD | 180.7万 USD | 111.7万 USD | 75.4万 USD |
| 研究開発 | 1500.3万 USD | 1363.4万 USD | 798.1万 USD | 781万 USD | 515.8万 USD |
| 販売・一般管理 | 3726万 USD | 2137.5万 USD | 1496.9万 USD | 1202万 USD | 1031.2万 USD |
| 営業費用 | 5176.1万 USD | 3500.9万 USD | 2295万 USD | 1983万 USD | 1547万 USD |
| 受取利息 | — | 155.7万 USD | 129.2万 USD | 25万 USD | — |
| 支払利息 | — | — | — | — | 15.7万 USD |
| 減価償却費と償却費 | 47.6万 USD | 28万 USD | 23.2万 USD | 18.8万 USD | 16.1万 USD |
| 営業利益 | −4911.2万 USD | −3350.3万 USD | −2114.3万 USD | −1871.3万 USD | −1471.6万 USD |
| 純利益 | −4878.6万 USD | −3200.5万 USD | −1991.6万 USD | −1849.1万 USD | −1491.8万 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。